Download presentation
Presentation is loading. Please wait.
Published byJasmine Samantha Fox Modified over 9 years ago
1
2001: This is the beginning of the new theory!
2
Inflammation and Atherosclerosis, Libby, Ridker, Maseri, Circ., 2001, 105, 1135-1143
3
The various stages of plaque development and when to interfere
4
Sequence of atherosclerotic process Normal vessel appearance Early plaqueObstructive plaquePlaque rupture Endothelial dysfunction begins Plaques increase in number and size Unstable angina Non-invasive tests normal Invasive tests abnormal Acute myocardial infarction - Cardiac failure Sudden death Level of vascular inflammation indicators (VCam, Ecam, MCP-1, MIF, IL-6, ox-LDL, CRP?) gradually rising as severity of disease increases So begin treatment HERE! Clinically non- detectable Clinically evident 10 20 40 ≥ 60 years
5
In certain regions of France, good food and wine, elsewhere in Western World, Fastfood and sweet drinks. It shows in longevity!
6
The french paradox what is the essential factor?
8
Multiple mechanisms form a beneficial cascade
10
Visuals of the various processes involved in the initiation of an atherosclerotic plaque and where the polyphenols stop inflammation
11
Rwpc’s and atherosclerosis Phases of leukocyte-endothelial interaction IIEndothelium Leukocyte Chemoattractants of endothelial surface (V- cam, E-cam, MCP-1, MIF etc)
12
Rwpc’s and atherosclerosis Phases of leukocyte-endothelial interaction IIILeukocyte Endothelium Recruitment Slow Rolling RWPC block MCP-1 and MIF and STOP inflammation HERE So block MCP-1, MIF early... …instead of the mechanical interventions later
13
Rwpc’s and atherosclerosis Phases of leukocyte-endothelial interaction IVLeukocyte Endothelium Recruitment Slow Rolling Adhesion So block MCP-1, MIF early... …instead of the mechanical interventions later
14
Rwpc’s and atherosclerosis Phases of leukocyte-endothelial interaction VLeukocyte Endothelium Plaque development by other proinflammatory molecules Recruitment Slow Rolling Selectins MCP-1, MIF Selectins MCP-1, MIF Adhesion Transmigration
15
Resveratrol, one of the polyphenols can avoid lesion development as effective as atorvastatin
16
The polyphenol Resveratrol protects against atherosclerosis in hyperlipidemic APOE3-Leiden.CETP mice Berbée JF et al. J. Nutr. Biochem. 2013;24(8):1423-1430 Control Atorvastatin Resveratrol Atorvastatin + Resveratrol
18
The proven effects of red wine polyphenols on the endothelium and smooth muscle cell
19
Thrombin Protective effects of Polyphenols on blood vessels (Schini, 2009) ROSROS CA 2+ PI3K/AktPI3K/Akt PP ROSROS VasodilationVasoconstriction Platelet aggregation VEGF expression MMP-2 activity Endothelial dysfunction Polyphenols ENDOTHELIAL CELL NO EDHF PDGF AB p38 P P VEGF Pro- MMP-2 T2 MT1- MMP SMOOTH MUSCLE CELL Angiogenesis ATHEROGENESIS
20
And in tabular form…
22
Food supplements play a significant role next to general lifestyle changes.
23
Smoking / Inflammation / Dyslipidaemia / Hypertension / Dysglycaemia Proinflammatory cytokines which ultimately lead to atherosclerosis (e.g. Vcam, Ecam, MCP-1, MIF, IL-6, TNFα, CD40L, CRP) No smoking, physical activity 5x week Red fruits, nuts, vegetables 600gr per day Oily fish 3x week or 6:1 EPA/DHA Olive oil 4 tblsp/day or oleuropein+hydroxyl tyrosol Red wine 4 glasses day or 500mgm In Vino Veritas Fibrinogen, PAI-1 Triglyceridemia OX_LDL C-reactive protein Endothelial Dysfunction Atheroma Lipid core ‘Messenger’ cytokine IL-6 And dark chocolate?
24
Let food be the medicine
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.